|
FAQs Bone
Densitometry (DXA) According to the world health Organization (WHO), osteoporosis - a potentially crippling disease characterized by the loss of bone tissue and a susceptibility to fracture - afflicts an estimated 30% of all women past menopause. Of these women, only a fraction have been properly diagnosed and currently receive treatment. Osteoporosis - called the "silent disease" - often does not produce symptoms until a fraction occurs. The bones most likely to break are the weightbearing hip and spine, and sometimes the forearm. Worldwide, a woman's lifetime risk of suffering a fracture due to osteoporosis may be as high as 40%. In some countries, a woman's risk of hip fracture alone - the most severe and painful of osteoporotic fractures - equals her combined risk of developing breast, uterine or ovarian cancer. In short, the prevalence of osteoporosis has reached worldwide epidemic proportions. ![]() Are
you at risk? Are you?
Do you have ?
Today, doctors are better equipped to detect and treat bone loss in its earliest stages, so as to prevent the disease or lessen its impact. Also, several drugs therapies, now on the market, have been shown to be clinically effective in slowing down or reversing the bone-loss process. Just as no physician would prescribe a medication for hypertension without first taking the patient's blood pressure, the diagnosis and the treatment of osteoporosis should begin with an objective, quantifiable measurement of the patient's bone mass or bone density. Bone densitometry
Unlike typical x-ray machines, radiation exposure during bone densitometry is extremely low - less than the radiation exposure during a coast-to-coast airline flight. The entire process takes only minutes to complete, depending on the number of sites scanned. It involves no injections or invasive procedures, and patients remain fully clothed. ![]() Bone Densitometry using DXA
THE EQUIPMENT: DXA is a fast, convenient and precise way to measure bone density to determine a woman's risk of developing osteoporosis. BONE DENSITY SCAN: Most common examination sites are the fracture-prone hip, spine and sometimes the forearm. Evaluation also includes measurement of height and weight, a thorough history, and risk assessment. DATA ANALYSIS: Bone Mineral Density (BMD) is calculated and compared to normal BMD values, matched for age and sex, to confirm or exclude osteoporosis. A low BMD by DXA may predict the likelihood of developing osteoporosis and can help determine a treatment plan. THE REPORT: The report consists of your bone density measurements, a comparison of your results against an extensive database of young, normal bone density values, a comparison of your results against a database of other patients your age and sex, and recommendations for treatment or prevention.
Radiology
Second Opinion |